FindTrial
Sign In

Study of the Analgesic Effect of Celiac Plexus Block performed during Major Abdominal Surgeries

Intraoperative Celiac Plexus Block for Post-opeartive Pain Relief in Upper Abdominal Surgeries- A Randomised Controlled Trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/01/039239
Enrollment
80
Registered
2022-01-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical

Interventions

Intervention1: intraoperative celiac plexus block: intraoperatively, a single shot celiac plexus block will be performed with 20ml of 0.25% bupivacaine. The expected time for performance of this proce

Sponsors

Cancer Institute WIA
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Elective major upper abdominal surgeries

Exclusion criteria

Exclusion criteria: 1. Patients not willing to participate in the study 2. Patients with tumours found to be inoperable at laparotomy 3. Patients requiring elective mechanical ventilation postoperatively 4. Known allergy to local anesthetics or any of the other drugs used 5. Contraindications for epidural analgesia

Design outcomes

Primary

MeasureTime frame
post-operative pain scoresTimepoint: 30min, 1hr, 4hr, 8hr, 12hr, 18hr, 24hr, 36hr, 48hr, 60hr and 72hr after surgery—

Secondary

MeasureTime frame
analgesic consumptionTimepoint: 30 min, 1hr, 4hr, 8hr, 12hr, 18hr, 24hr, 36hr, 48hr, 60hr and 72 hr after surgery—

Countries

India

Contacts

Public ContactH A Subramanian

Cancer Institute (WIA)

drsubra@gmail.com9940417230

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026